Inspire Veterinary Partners, Inc. (IVP)
USD 0.19
(-4.48%)
USD 0.19
(-4.48%)
| Breakdown | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|
| Revenue | 16.67 Million | 9.83 Million | 2.54 Million | - |
| Cost of Revenue | 13.12 Million | 7.28 Million | 1.71 Million | - |
| Gross Profit | 3.55 Million | 2.54 Million | 829.29 Thousand | - |
| Operating Expenses | 9.47 Million | 6.06 Million | 1.87 Million | 5520.00 |
| Selling, General and Administrative Expenses | 9.47 Million | 5.46 Million | 1.79 Million | 5520.00 |
| Research and Development Expenses | - | - | - | - |
| Other Expenses | 1.26 Million | 357.00 | -14.86 Thousand | - |
| Cost and Expenses | 23.86 Million | 13.35 Million | 3.59 Million | 5520.00 |
| Operating Income | -7.19 Million | -3.51 Million | -1.04 Million | -5520.00 |
| Interest Expense | 2.53 Million | 1.42 Million | 194.81 Thousand | - |
| Income Tax Expense | - | -30.09 Thousand | 74.33 Thousand | - |
| Earnings before Tax | -14.79 Million | -4.94 Million | -1.25 Million | -5520.00 |
| Net Income | -14.79 Million | -4.91 Million | -1.33 Million | -5520.00 |
| Earnings Per Share Basic | -225.09 | -43.96 | -11.91 | -0.13 |
| Earnings Per Share Diluted | -225.09 | -43.96 | -11.91 | -0.13 |
| Weighted Average Shares Outstanding | 66.92 Thousand | 111.72 Thousand | 111.72 Thousand | 43.03 Thousand |
| Weighted Average Shares Outstanding (Diluted) | 66.92 Thousand | 111.72 Thousand | 111.72 Thousand | 43.03 Thousand |
| Gross Margin | 0.21 | 0.26 | 0.33 | - |
| EBIT Margin | -0.65 | -0.30 | -0.38 | - |
| Profit Margin | -0.89 | -0.50 | -0.52 | - |
| EBITDA | -10.83 Million | -2.9 Million | -977.45 Thousand | - |
| Earnings Before Tax Margin | -0.43 | -0.36 | -0.41 | - |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 FY | 2023 Q4 | 2023 Q3 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Revenue | 4.39 Million | 4.83 Million | 16.67 Million | 3.78 Million | 4.11 Million | 4.48 Million |
| Cost of Revenue | 3.7 Million | 4.09 Million | 14.37 Million | 3.97 Million | 3.05 Million | 3.23 Million |
| Gross Profit | 684.71 Thousand | 739.11 Thousand | 2.3 Million | -194.67 Thousand | 1.05 Million | 1.25 Million |
| Operating Expenses | 2.21 Million | 2.87 Million | 9.47 Million | 2.22 Million | 3.87 Million | 2.18 Million |
| Selling, General and Administrative Expenses | 2.21 Million | 2.87 Million | - | 2.22 Million | 3.56 Million | 1.88 Million |
| Research and Development Expenses | - | - | - | - | - | - |
| Other Expenses | -4768.00 | 2.11 Million | -4.13 Million | -84.00 | -4.13 Million | -9458.00 |
| Cost and Expenses | 5.92 Million | 6.96 Million | 23.85 Million | 6.2 Million | 6.93 Million | 5.42 Million |
| Operating Income | -1.53 Million | -2.13 Million | -7.17 Million | -2.42 Million | -2.83 Million | -932.96 Thousand |
| Interest Expense | 988.05 Thousand | 559.28 Thousand | 2.53 Million | 793.29 Thousand | 914.6 Thousand | 285.37 Thousand |
| Income Tax Expense | 6330.00 | -3.00 | 3.00 | 3.00 | -3.22 Million | 275.91 Thousand |
| Earnings before Tax | -3.38 Million | -3.42 Million | -14.79 Million | -4.14 Million | -7.88 Million | -1.22 Million |
| Net Income | -3.38 Million | -3.42 Million | -14.79 Million | -4.14 Million | -7.88 Million | -1.22 Million |
| Earnings Per Share Basic | -0.70 | -8.44 | - | -37.88 | -122.53 | -10.99 |
| Earnings Per Share Diluted | -0.70 | -8.44 | - | -37.88 | -122.53 | -10.99 |
| Weighted Average Shares Outstanding | 4.82 Million | 405.48 Thousand | 66.92 Thousand | 109.33 Thousand | 64.34 Thousand | 111.72 Thousand |
| Weighted Average Shares Outstanding (Diluted) | 4.82 Million | 405.48 Thousand | 66.92 Thousand | 109.33 Thousand | 64.34 Thousand | 111.72 Thousand |
| Gross Margin | 0.16 | 0.15 | 0.14 | -0.05 | 0.26 | 0.28 |
| EBIT Margin | -0.22 | -0.36 | - | -0.54 | -1.60 | -0.14 |
| Profit Margin | -0.77 | -0.71 | -0.89 | -1.09 | -1.91 | -0.27 |
| EBITDA | -980.12 Thousand | -1.73 Million | - | -2.03 Million | -6.61 Million | -609.52 Thousand |
| Earnings Before Tax Margin | -0.35 | -0.44 | -0.43 | -0.64 | -0.69 | -0.21 |
PCTY
MEDX
ALD
2404
2750
BPPPF